Farallon Capital Management as of June 30, 2018
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 95 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 16.1 | $2.6B | 9.6M | 271.28 | |
| Altaba | 8.6 | $1.4B | 19M | 73.21 | |
| Aetna | 7.7 | $1.2B | 6.8M | 183.50 | |
| Express Scripts Holding | 3.7 | $599M | 7.8M | 77.21 | |
| Dr Pepper Snapple | 3.7 | $596M | 4.9M | 122.00 | |
| Rockwell Collins | 3.6 | $576M | 4.3M | 134.68 | |
| Dell Technologies Inc Class V equity | 3.2 | $514M | 6.1M | 84.58 | |
| Wabtec Corporation (WAB) | 2.6 | $422M | 4.3M | 98.58 | |
| Facebook Inc cl a (META) | 2.5 | $411M | 2.1M | 194.32 | |
| Iqvia Holdings (IQV) | 2.5 | $408M | 4.1M | 99.82 | |
| Xl | 2.5 | $407M | 7.3M | 55.95 | |
| Alphabet Inc Class C cs (GOOG) | 2.4 | $395M | 354k | 1115.65 | |
| Visa (V) | 2.3 | $368M | 2.8M | 132.45 | |
| Playa Hotels & Resorts Nv (PLYA) | 2.0 | $331M | 31M | 10.80 | |
| General Dynamics Corporation (GD) | 1.9 | $317M | 1.7M | 186.41 | |
| Transunion (TRU) | 1.9 | $300M | 4.2M | 71.64 | |
| Nxp Semiconductors N V (NXPI) | 1.8 | $292M | 2.7M | 109.27 | |
| Ihs Markit | 1.6 | $262M | 5.1M | 51.59 | |
| Charter Communications Inc New Cl A cl a (CHTR) | 1.6 | $257M | 877k | 293.21 | |
| Microsoft Corporation (MSFT) | 1.5 | $249M | 2.5M | 98.61 | |
| Anthem (ELV) | 1.5 | $246M | 1.0M | 238.03 | |
| LogMeIn | 1.3 | $214M | 2.1M | 103.25 | |
| Fidelity National Information Services (FIS) | 1.3 | $210M | 2.0M | 106.03 | |
| Gilead Sciences (GILD) | 1.3 | $207M | 2.9M | 70.84 | |
| Verisk Analytics (VRSK) | 1.2 | $196M | 1.8M | 107.64 | |
| Fox News | 1.1 | $174M | 3.5M | 49.27 | |
| Citrix Systems | 1.0 | $167M | 1.6M | 104.84 | |
| Liberty Global Inc C | 0.9 | $147M | 5.5M | 26.61 | |
| Liberty Global Inc Com Ser A | 0.9 | $147M | 5.3M | 27.54 | |
| AstraZeneca (AZN) | 0.8 | $135M | 3.9M | 35.11 | |
| Enanta Pharmaceuticals (ENTA) | 0.8 | $125M | 1.1M | 115.90 | |
| Radius Health | 0.7 | $120M | 4.1M | 29.47 | |
| CIGNA Corporation | 0.7 | $114M | 671k | 169.95 | |
| Fibrogen (FGEN) | 0.7 | $108M | 1.7M | 62.60 | |
| Equifax (EFX) | 0.7 | $105M | 839k | 125.11 | |
| Ggp | 0.6 | $104M | 5.1M | 20.43 | |
| Sage Therapeutics (SAGE) | 0.6 | $98M | 625k | 156.53 | |
| Ascendis Pharma A S (ASND) | 0.6 | $97M | 1.5M | 66.52 | |
| Andeavor | 0.5 | $80M | 610k | 131.18 | |
| Array BioPharma | 0.5 | $78M | 4.7M | 16.78 | |
| Zogenix | 0.5 | $75M | 1.7M | 44.20 | |
| Biogen Idec (BIIB) | 0.5 | $72M | 249k | 290.24 | |
| Myokardia | 0.5 | $74M | 1.5M | 49.65 | |
| Acceleron Pharma | 0.4 | $68M | 1.4M | 48.52 | |
| Twenty-first Century Fox | 0.4 | $61M | 1.2M | 49.69 | |
| Avista Corporation (AVA) | 0.4 | $59M | 1.1M | 52.66 | |
| Amicus Therapeutics (FOLD) | 0.3 | $57M | 3.7M | 15.62 | |
| Iovance Biotherapeutics (IOVA) | 0.3 | $57M | 4.4M | 12.80 | |
| Sina Corporation | 0.3 | $54M | 635k | 84.69 | |
| Global Blood Therapeutics In | 0.3 | $54M | 1.2M | 45.20 | |
| Novocure Ltd ord (NVCR) | 0.3 | $50M | 1.6M | 31.30 | |
| Crispr Therapeutics (CRSP) | 0.3 | $51M | 861k | 58.76 | |
| Envision Healthcare | 0.3 | $48M | 1.1M | 44.01 | |
| Cavium | 0.3 | $47M | 545k | 86.50 | |
| Alnylam Pharmaceuticals (ALNY) | 0.2 | $41M | 415k | 98.49 | |
| Mirati Therapeutics | 0.2 | $37M | 744k | 49.30 | |
| Anheuser-Busch InBev NV (BUD) | 0.2 | $36M | 359k | 100.76 | |
| Sutherland Asset Management reit | 0.2 | $36M | 2.2M | 16.25 | |
| Hrg | 0.2 | $30M | 2.3M | 13.09 | |
| Savara (SVRA) | 0.2 | $25M | 2.2M | 11.32 | |
| Dynavax Technologies (DVAX) | 0.1 | $22M | 1.4M | 15.25 | |
| Intellia Therapeutics (NTLA) | 0.1 | $23M | 840k | 27.36 | |
| Progenics Pharmaceuticals | 0.1 | $21M | 2.7M | 8.04 | |
| Bemis Company | 0.1 | $19M | 443k | 42.21 | |
| Codexis (CDXS) | 0.1 | $16M | 1.1M | 14.40 | |
| Amarin Corporation (AMRN) | 0.1 | $14M | 4.5M | 3.09 | |
| Chemocentryx | 0.1 | $15M | 1.2M | 13.17 | |
| Bellicum Pharma | 0.1 | $15M | 2.0M | 7.38 | |
| Voyager Therapeutics (VYGR) | 0.1 | $15M | 768k | 19.54 | |
| Aptinyx | 0.1 | $14M | 597k | 24.17 | |
| Zafgen | 0.1 | $13M | 1.3M | 10.23 | |
| Shire | 0.1 | $12M | 70k | 168.81 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.1 | $12M | 551k | 21.50 | |
| Coherus Biosciences (CHRS) | 0.1 | $12M | 845k | 14.00 | |
| Zymeworks | 0.1 | $11M | 755k | 14.78 | |
| Zealand Pharma A/s- | 0.1 | $11M | 900k | 12.68 | |
| Immunomedics | 0.1 | $9.5M | 400k | 23.67 | |
| Pinnacle Foods Inc De | 0.1 | $9.4M | 145k | 65.06 | |
| Comstock Res Inc note 7.750% 4/0 | 0.1 | $10M | 10M | 0.99 | |
| Avrobio Ord (AVRO) | 0.1 | $10M | 353k | 28.56 | |
| Akorn | 0.1 | $7.3M | 440k | 16.59 | |
| Voya Financial (VOYA) | 0.1 | $8.7M | 185k | 47.00 | |
| Protagonist Therapeutics (PTGX) | 0.0 | $6.1M | 910k | 6.72 | |
| Synlogic | 0.0 | $6.7M | 685k | 9.83 | |
| Translate Bio | 0.0 | $5.1M | 400k | 12.65 | |
| Sanofi Aventis Wi Conval Rt | 0.0 | $3.4M | 6.8M | 0.50 | |
| Pfenex | 0.0 | $3.2M | 600k | 5.41 | |
| Tyme Technologies | 0.0 | $3.0M | 948k | 3.16 | |
| Xeris Pharmaceuticals | 0.0 | $3.0M | 160k | 18.98 | |
| Spectrum Pharmaceuticals | 0.0 | $1.0M | 50k | 20.96 | |
| Veon | 0.0 | $2.4M | 1.0M | 2.38 | |
| Morphosys (MOR) | 0.0 | $2.2M | 72k | 30.34 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.0 | $2.0M | 115k | 17.35 | |
| Surface Oncology | 0.0 | $1.6M | 100k | 16.31 | |
| Kezar Life Sciences (KZR) | 0.0 | $1.3M | 77k | 17.29 |
